SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel

Din, S; Kent, A; Pollok, RC; Meade, S; Kennedy, NA; Arnott, I; Beattie, RM; Chua, F; Cooney, R; Dart, RJ; et al. Din, S; Kent, A; Pollok, RC; Meade, S; Kennedy, NA; Arnott, I; Beattie, RM; Chua, F; Cooney, R; Dart, RJ; Galloway, J; Gaya, DR; Ghosh, S; Griffiths, M; Hancock, L; Hansen, R; Hart, A; Lamb, CA; Lees, CW; Limdi, JK; Lindsay, JO; Patel, K; Powell, N; Murray, CD; Probert, C; Raine, T; Selinger, C; Sebastian, S; Smith, PJ; Tozer, P; Ustianowski, A; Younge, L; Samaan, MA; Irving, PM (2020) Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Gut, 69 (10). pp. 1769-1777. ISSN 1468-3288 https://doi.org/10.1136/gutjnl-2020-321927
SGUL Authors: Pollok, Richard Charles G

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (678kB) | Preview

Abstract

Objective Management of acute severe UC (ASUC) during the novel COVID-19 pandemic presents significant dilemmas. We aimed to provide COVID-19-specific guidance using current British Society of Gastroenterology (BSG) guidelines as a reference point. Design We convened a RAND appropriateness panel comprising 14 gastroenterologists and an IBD nurse consultant supplemented by surgical and COVID-19 experts. Panellists rated the appropriateness of interventions for ASUC in the context of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. Median scores and disagreement index (DI) were calculated. Results were discussed at a moderated meeting prior to a second survey. Results Panellists recommended that patients with ASUC should be isolated throughout their hospital stay and should have a SARS-CoV-2 swab performed on admission. Patients with a positive swab should be discussed with COVID-19 specialists. As per BSG guidance, intravenous hydrocortisone was considered appropriate as initial management; only in patients with COVID-19 pneumonia was its use deemed uncertain. In patients requiring rescue therapy, infliximab with continuing steroids was recommended. Delaying colectomy because of COVID-19 was deemed inappropriate. Steroid tapering as per BSG guidance was deemed appropriate for all patients apart from those with COVID-19 pneumonia in whom a 4–6 week taper was preferred. Post-ASUC maintenance therapy was dependent on SARS-CoV-2 status but, in general, biologics were more likely to be deemed appropriate than azathioprine or tofacitinib. Panellists deemed prophylactic anticoagulation postdischarge to be appropriate in patients with a positive SARS-CoV-2 swab. Conclusion We have suggested COVID-19-specific adaptations to the BSG ASUC guideline using a RAND panel.

Item Type: Article
Additional Information: © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: IBD clinical, clinical decision making, ulcerative colitis, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, Gastroenterology & Hepatology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Gut
ISSN: 1468-3288
Language: eng
Dates:
DateEvent
7 September 2020Published
8 June 2020Published Online
26 May 2020Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
MR/T005564/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
PubMed ID: 32513653
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/112004
Publisher's version: https://doi.org/10.1136/gutjnl-2020-321927

Actions (login required)

Edit Item Edit Item